vs

Side-by-side financial comparison of DaVita (DVA) and DXC Technology Co (DXC). Click either name above to swap in a different company.

DaVita is the larger business by last-quarter revenue ($3.6B vs $3.2B, roughly 1.1× DXC Technology Co). DaVita runs the higher net margin — 6.5% vs 3.4%, a 3.1% gap on every dollar of revenue. On growth, DaVita posted the faster year-over-year revenue change (12.3% vs -1.0%). Over the past eight quarters, DaVita's revenue compounded faster (6.6% CAGR vs -2.9%).

DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.

DXC Technology Company is an American multinational information technology (IT) services and consulting company headquartered in Ashburn, Virginia.

DVA vs DXC — Head-to-Head

Bigger by revenue
DVA
DVA
1.1× larger
DVA
$3.6B
$3.2B
DXC
Growing faster (revenue YoY)
DVA
DVA
+13.3% gap
DVA
12.3%
-1.0%
DXC
Higher net margin
DVA
DVA
3.1% more per $
DVA
6.5%
3.4%
DXC
Faster 2-yr revenue CAGR
DVA
DVA
Annualised
DVA
6.6%
-2.9%
DXC

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
DVA
DVA
DXC
DXC
Revenue
$3.6B
$3.2B
Net Profit
$234.2M
$107.0M
Gross Margin
Operating Margin
15.5%
8.2%
Net Margin
6.5%
3.4%
Revenue YoY
12.3%
-1.0%
Net Profit YoY
43.8%
87.7%
EPS (diluted)
$3.22
$0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DVA
DVA
DXC
DXC
Q1 26
$3.6B
Q4 25
$3.6B
$3.2B
Q3 25
$3.4B
$3.2B
Q2 25
$3.4B
$3.2B
Q1 25
$3.2B
$3.2B
Q4 24
$3.3B
$3.2B
Q3 24
$3.3B
$3.2B
Q2 24
$3.2B
$3.2B
Net Profit
DVA
DVA
DXC
DXC
Q1 26
$234.2M
Q4 25
$234.2M
$107.0M
Q3 25
$150.3M
$36.0M
Q2 25
$199.3M
$16.0M
Q1 25
$162.9M
$264.0M
Q4 24
$259.3M
$57.0M
Q3 24
$214.7M
$42.0M
Q2 24
$222.7M
$26.0M
Operating Margin
DVA
DVA
DXC
DXC
Q1 26
15.5%
Q4 25
15.5%
8.2%
Q3 25
14.8%
8.0%
Q2 25
15.9%
6.8%
Q1 25
13.6%
7.3%
Q4 24
17.2%
8.9%
Q3 24
16.4%
8.6%
Q2 24
15.9%
6.9%
Net Margin
DVA
DVA
DXC
DXC
Q1 26
6.5%
Q4 25
6.5%
3.4%
Q3 25
4.4%
1.1%
Q2 25
5.9%
0.5%
Q1 25
5.1%
8.3%
Q4 24
7.9%
1.8%
Q3 24
6.6%
1.3%
Q2 24
7.0%
0.8%
EPS (diluted)
DVA
DVA
DXC
DXC
Q1 26
$3.22
Q4 25
$3.22
$0.61
Q3 25
$2.04
$0.20
Q2 25
$2.58
$0.09
Q1 25
$2.00
$1.42
Q4 24
$3.08
$0.31
Q3 24
$2.50
$0.23
Q2 24
$2.50
$0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DVA
DVA
DXC
DXC
Cash + ST InvestmentsLiquidity on hand
$700.7M
$1.7B
Total DebtLower is stronger
$10.2B
$3.1B
Stockholders' EquityBook value
$-651.1M
$3.1B
Total Assets
$17.5B
$13.2B
Debt / EquityLower = less leverage
0.98×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DVA
DVA
DXC
DXC
Q1 26
$700.7M
Q4 25
$700.7M
$1.7B
Q3 25
$736.5M
$1.9B
Q2 25
$739.4M
$1.8B
Q1 25
$511.9M
$1.8B
Q4 24
$846.0M
$1.7B
Q3 24
$1.1B
$1.2B
Q2 24
$437.2M
$1.3B
Total Debt
DVA
DVA
DXC
DXC
Q1 26
$10.2B
Q4 25
$10.2B
$3.1B
Q3 25
$10.2B
$2.4B
Q2 25
$10.1B
$3.1B
Q1 25
$9.6B
$3.0B
Q4 24
$9.2B
$3.6B
Q3 24
$9.3B
$3.8B
Q2 24
$8.5B
$3.8B
Stockholders' Equity
DVA
DVA
DXC
DXC
Q1 26
$-651.1M
Q4 25
$-651.1M
$3.1B
Q3 25
$-571.9M
$3.1B
Q2 25
$-369.6M
$3.2B
Q1 25
$-267.1M
$3.2B
Q4 24
$121.1M
$3.0B
Q3 24
$386.7M
$3.0B
Q2 24
$632.9M
$2.9B
Total Assets
DVA
DVA
DXC
DXC
Q1 26
$17.5B
Q4 25
$17.5B
$13.2B
Q3 25
$17.6B
$13.6B
Q2 25
$17.5B
$13.4B
Q1 25
$17.1B
$13.2B
Q4 24
$17.3B
$13.0B
Q3 24
$17.5B
$13.5B
Q2 24
$17.0B
$13.4B
Debt / Equity
DVA
DVA
DXC
DXC
Q1 26
Q4 25
0.98×
Q3 25
0.77×
Q2 25
0.98×
Q1 25
0.93×
Q4 24
75.76×
1.22×
Q3 24
23.95×
1.28×
Q2 24
13.35×
1.32×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DVA
DVA
DXC
DXC
Operating Cash FlowLast quarter
$414.0M
Free Cash FlowOCF − Capex
$359.0M
FCF MarginFCF / Revenue
11.2%
Capex IntensityCapex / Revenue
1.7%
Cash ConversionOCF / Net Profit
3.87×
TTM Free Cash FlowTrailing 4 quarters
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DVA
DVA
DXC
DXC
Q1 26
Q4 25
$540.7M
$414.0M
Q3 25
$841.5M
$409.0M
Q2 25
$324.2M
$186.0M
Q1 25
$180.0M
$315.0M
Q4 24
$547.6M
$650.0M
Q3 24
$810.4M
$195.0M
Q2 24
$798.8M
$238.0M
Free Cash Flow
DVA
DVA
DXC
DXC
Q1 26
Q4 25
$395.3M
$359.0M
Q3 25
$675.4M
$365.0M
Q2 25
$203.1M
$143.0M
Q1 25
$36.8M
$238.0M
Q4 24
$377.0M
$568.0M
Q3 24
$671.4M
$154.0M
Q2 24
$674.1M
$190.0M
FCF Margin
DVA
DVA
DXC
DXC
Q1 26
Q4 25
10.9%
11.2%
Q3 25
19.7%
11.5%
Q2 25
6.0%
4.5%
Q1 25
1.1%
7.5%
Q4 24
11.4%
17.6%
Q3 24
20.6%
4.8%
Q2 24
21.2%
5.9%
Capex Intensity
DVA
DVA
DXC
DXC
Q1 26
Q4 25
4.0%
1.7%
Q3 25
4.9%
1.4%
Q2 25
3.6%
1.4%
Q1 25
4.4%
2.4%
Q4 24
5.2%
2.5%
Q3 24
4.3%
1.3%
Q2 24
3.9%
1.5%
Cash Conversion
DVA
DVA
DXC
DXC
Q1 26
Q4 25
2.31×
3.87×
Q3 25
5.60×
11.36×
Q2 25
1.63×
11.63×
Q1 25
1.10×
1.19×
Q4 24
2.11×
11.40×
Q3 24
3.77×
4.64×
Q2 24
3.59×
9.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DVA
DVA

Segment breakdown not available.

DXC
DXC

GIS Segment$1.6B50%
CES Segment$1.3B40%
Insurance Segment$321.0M10%

Related Comparisons